dimethylarsinous acid has been researched along with arsenic trioxide in 3 studies
| Studies (dimethylarsinous acid) | Trials (dimethylarsinous acid) | Recent Studies (post-2010) (dimethylarsinous acid) | Studies (arsenic trioxide) | Trials (arsenic trioxide) | Recent Studies (post-2010) (arsenic trioxide) |
|---|---|---|---|---|---|
| 72 | 1 | 34 | 3,119 | 160 | 1,507 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, Z; Le, XC; Lu, X; Wang, Z; Zhou, J | 1 |
| Fu, YJ; Naranmandura, H; Rehman, K; Sun, TF; Sun, WH; Wang, QQ; Wu, B; Wu, Y; Zhang, YF; Zhou, XY | 1 |
| Bu, N; Cao, FL; Naranmandura, H; Wang, QQ; Zhang, YF; Zhou, J; Zhou, XY | 1 |
1 trial(s) available for dimethylarsinous acid and arsenic trioxide
| Article | Year |
|---|---|
Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Topics: Adult; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Arsenites; Cacodylic Acid; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Leukemia, Promyelocytic, Acute; Male; Methylation; Middle Aged; Oxidation-Reduction; Oxides | 2004 |
2 other study(ies) available for dimethylarsinous acid and arsenic trioxide
| Article | Year |
|---|---|
Trivalent methylated arsenic metabolites induce apoptosis in human myeloid leukemic HL-60 cells through generation of reactive oxygen species.
Topics: Apoptosis; Arsenic; Arsenic Trioxide; Arsenicals; Arsenites; Cacodylic Acid; HL-60 Cells; Humans; Oxides; Reactive Oxygen Species | 2014 |
Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARĪ± protein degradation.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Biotransformation; Cacodylic Acid; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; HEK293 Cells; HeLa Cells; Humans; Leukemia, Promyelocytic, Acute; Methylation; Nuclear Proteins; Oncogene Proteins, Fusion; Organometallic Compounds; Oxides; Promyelocytic Leukemia Protein; Proteasome Endopeptidase Complex; Protein Binding; Protein Interaction Domains and Motifs; Proteolysis; Sumoylation; Time Factors; Transcription Factors; Tumor Suppressor Proteins | 2015 |